CEO Chris Bunka of Lexaria Bioscience Corp. (OTCQB: LXRP) - March '18 update

Mar 12, 12:30 PM

CEO Chris Bunka of Lexaria Bioscience Corp. (OTCQB: LXRP), returns to the show to discuss bio technology research and their patented drug delivery platform.

OTCQB: LXRP # DehydraTECH™ # lipophilic enhancement technology # ViPova # intellectual property # R&D # licensing model #  Bio Technology # bioavailibility # CBD Oil # effective drug delivery # Energy Bar # Hemp Tea # micro cap companies # nicotine patents # odor masking # royalty revenues # US Patent # Vipova